Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Karner

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2023
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapyBrane Grambozov, Forough Kalantari, Mohsen Beheshti, et al.
Radiation Oncology (London, England)|March 17, 2019
Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacersAndreas Schörghofer, Martin Drerup, Thomas Kunit, et al.
Annals of Surgery|April 24, 2009
Neuromuscular electrical stimulation reduces skeletal muscle protein degradation and stimulates insulin-like growth factors in an age- and current-dependent manner: a randomized, controlled clinical trial in major abdominal surgical patientsEva Maria Strasser, Stefan Stättner, Josef Karner, et al.
Cancers|February 15, 2022
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLCBrane Grambozov, Markus Stana, Bernhard Kaiser, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Carbon Monoxide Diffusing Capacity (DL<sub>CO</sub>) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage IIIMarkus Stana, Brane Grambozov, Christoph Gaisberger, et al.
Cancers|April 13, 2023
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis RateMarkus Stana, Brane Grambozov, Josef Karner, et al.
Biomedicines|August 28, 2025
Delta Changes in [<sup>18</sup>F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-ChemoimmunotherapyBrane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, et al.
Carcinogenesis|September 25, 2007
FGF18 in colorectal tumour cells: autocrine and paracrine effectsGudrun Sonvilla, Sigrid Allerstorfer, Stefan Stättner, et al.
Breast Cancer (Tokyo, Japan)|December 5, 2021
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Cancers|February 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM ApproachesSara Vockner, Matthias Mattke, Ivan M Messner, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2023
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapyBrane Grambozov, Forough Kalantari, Mohsen Beheshti, et al.
Radiation Oncology (London, England)|March 17, 2019
Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacersAndreas Schörghofer, Martin Drerup, Thomas Kunit, et al.
Annals of Surgery|April 24, 2009
Neuromuscular electrical stimulation reduces skeletal muscle protein degradation and stimulates insulin-like growth factors in an age- and current-dependent manner: a randomized, controlled clinical trial in major abdominal surgical patientsEva Maria Strasser, Stefan Stättner, Josef Karner, et al.
Cancers|February 15, 2022
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLCBrane Grambozov, Markus Stana, Bernhard Kaiser, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Carbon Monoxide Diffusing Capacity (DL<sub>CO</sub>) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage IIIMarkus Stana, Brane Grambozov, Christoph Gaisberger, et al.
Cancers|April 13, 2023
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis RateMarkus Stana, Brane Grambozov, Josef Karner, et al.
Biomedicines|August 28, 2025
Delta Changes in [<sup>18</sup>F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-ChemoimmunotherapyBrane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, et al.
Carcinogenesis|September 25, 2007
FGF18 in colorectal tumour cells: autocrine and paracrine effectsGudrun Sonvilla, Sigrid Allerstorfer, Stefan Stättner, et al.
Breast Cancer (Tokyo, Japan)|December 5, 2021
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Cancers|February 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM ApproachesSara Vockner, Matthias Mattke, Ivan M Messner, et al.
Pageof 4